Shots: Indivumed to receive upfront from Evotec, for accessing Indivumed’s database “IndivuType” and both companies will jointly invest in data analysis, target identification, validation, and drug discovery. Evotec will be […]readmore
Tags : CRC
Shots: The IND submission under FDA is in response to onset P-I/II clinical trial for MRTX849, to evaluate its safety, PK & tolerability With the IND acceptance, the trial will […]readmore
Biosimilars
Pharma
Celltrion’s Bevacizumab Biosimilar (CT-P16) Enters into Global Phase III Clinical
Shots: • Celltrion has completed Phase I on safety and efficacy of CT-P16 in June 18 • CT-P16 extended to Phase III as planned by submission […]readmore